January 19, 2025 - 14:20

On Monday, linebacker Jack Kiser is set to make history by playing in his 70th and final game for Notre Dame as the Irish take on Ohio State in the College Football Playoff title game. This remarkable achievement not only solidifies Kiser's legacy on the field but also highlights his dedication and commitment to the program.
Throughout his career, Kiser has demonstrated exceptional skill and leadership, earning the respect of teammates and coaches alike. His journey began with hard work and determination, attributes that have propelled him to the forefront of Notre Dame football history. As he steps onto the field for the last time, Kiser's contributions extend beyond statistics; he has been a vital part of the team's culture and success.
In addition to his athletic accomplishments, Kiser has excelled academically, being recognized as a top business student. Balancing rigorous training with academic responsibilities, he exemplifies the spirit of a true student-athlete. As the game approaches, Kiser's dual legacy as a record-setting player and a dedicated scholar will undoubtedly leave a lasting impact on Notre Dame.
June 27, 2026 - 07:59
Gilbert Chamber Foundation brings AI basics to local businessesBusiness owners in Gilbert and the East Valley are getting a hands-on look at how artificial intelligence could keep them competitive. The Gilbert Chamber Foundation has introduced a new initiative...
June 26, 2026 - 18:02
Meet ‘Pepper’ Baumer, The Man With Hot Sauce In His BloodHot sauce has become one of the fastest-growing sectors in the food industry, and few people understand that heat better than `Pepper` Baumer. As the third-generation owner of Crystal, a...
June 26, 2026 - 11:50
‘Disgusting and vile’: Locals react to arrest of Tampa business owner on AI child porn chargesA Tampa business owner is behind bars this week, facing more than 100 felony charges after authorities say he used artificial intelligence to create child pornography. Local residents and fellow...
June 25, 2026 - 20:17
Investigational heart drug for nonobstructive HCM one step closer to FDA approvalAn experimental oral medication for a specific type of hypertrophic cardiomyopathy is advancing toward potential U.S. approval. The drug, known as ninerafaxstat, is being developed for patients...